Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Mangoceuticals, Inc. (MGRX) had Stock-Based Compensation of $1.94M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.11M |
|
$-4.84M |
|
$0.05M |
|
$0.06M |
|
$4.96M |
|
$-4.85M |
|
$0.01M |
|
$-4.84M |
|
$-4.84M |
|
$-4.84M |
|
$-4.84M |
|
$-4.84M |
|
$-4.84M |
|
$-4.85M |
|
$-4.44M |
|
4.59M |
|
4.59M |
|
$-1.29 |
|
$-1.29 |
|
| Balance Sheet Financials | |
$0.18M |
|
$0.00M |
|
$21.58M |
|
$21.75M |
|
$1.50M |
|
-- |
|
-- |
|
$1.50M |
|
$20.25M |
|
$-1.28M |
|
$20.25M |
|
7.14M |
|
| Cash Flow Statement Financials | |
$-2.27M |
|
$0.00M |
|
$2.29M |
|
$0.06M |
|
$0.08M |
|
$0.02M |
|
|
Stock-Based Compensation |
$1.94M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
56.78% |
|
-4440.00% |
|
-4440.00% |
|
-- |
|
-4427.47% |
|
-4427.38% |
|
$-2.27M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-23.90% |
|
378.02% |
|
-22.25% |
|
-23.90% |
|
$2.83 |
|
$-0.50 |
|
$-0.50 |
|